Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Treasury Shares: 2020-2025

Historic Treasury Shares for AC Immune (ACIU) over the last 5 years, with Sep 2025 value amounting to -$272,516.

  • AC Immune's Treasury Shares fell 8.31% to -$272,516 in Q3 2025 from the same period last year, while for Sep 2025 it was -$272,516, marking a year-over-year decrease of 8.31%. This contributed to the annual value of -$272,516 for FY2025, which is N/A change from last year.
  • Per AC Immune's latest filing, its Treasury Shares stood at -$272,516 for Q3 2025, which was down 103,392.37% from -$263.32 recorded in Q2 2025.
  • AC Immune's Treasury Shares' 5-year high stood at $134,478 during Q4 2021, with a 5-year trough of -$135.1 million in Q3 2021.
  • Its 3-year average for Treasury Shares is $5.9 million, with a median of $5.7 million in 2024.
  • Data for AC Immune's Treasury Shares shows a peak YoY climbed of 2.52% (in 2024) over the last 5 years.
  • AC Immune's Treasury Shares (Quarterly) stood at $134,478 in 2021, then decreased by 4.29% to $128,715 in 2022, then dropped by 8.04% to $118,372 in 2023, then plummeted by 100.21% to -$248.85 in 2024, then dropped by 8.31% to -$272,516 in 2025.
  • Its Treasury Shares stands at -$272,516 for Q3 2025, versus -$263.32 for Q2 2025 and -$242,471 for Q1 2025.